市場調査レポート

心房細動市場 - 世界の業界分析、規模、シェア、成長、動向および予測

Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 286480
出版日 ページ情報 英文 88 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
心房細動市場 - 世界の業界分析、規模、シェア、成長、動向および予測 Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2013年10月09日 ページ情報: 英文 88 Pages
概要

当レポートでは、心房細動市場における競合環境、地域別動向、2012年の市場シェアと2019年までの予測、参入企業のプロファイルなどをまとめ、概略下記の構成で取り上げております。

第1章 序論

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
  • ポーターズファイブフォース分析

第4章 治療タイプ別心房細動市場

  • 概要
    • 世界の心房細動市場:2011〜2019年
  • 心房細動に対する薬理学的治療市場
    • 世界市場:2011〜2019年
    • 抗不整脈薬市場
    • 抗凝固薬市場
  • 心房細動に対する非薬理学的治療市場
    • 概要:非薬理学的治療の比較分析
    • 世界市場:2011〜2019年
    • カテーテルアブレーション治療
    • Maze法による手術
    • 電気的除細動市場

第5章 地域別市場

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第6章 競合環境

第7章 提言

  • 特に中国やブラジルなど、新興市場への投資
  • mini-Maze法やカテーテルアブレーションなどの新興技術への注力

第8章 企業プロファイル

  • AtriCure, Inc.
  • Biosense Webster, Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc.
  • Sanofi Aventis
  • St. Jude Medical, Inc.
  • Johnson and Johnson Ltd

図表

目次

Title: Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.

Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart's electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. Being a potentially life threatening disease and expensive to treat, the overall healthcare system views the treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation market from the point of view of various pharmacological and non-pharmacological treatment products used for the treatment of AF.

The pharmacological AF treatment market has been further classified into the specific drugs commonly used for treating AF, namely anti-arrythmics and anti-coagulants. The non-pharmacological atrial fibrillation devices market has been further sub-divided into therapeutic procedures such as catheter ablation procedures, maze surgery and electric cardioversion. The major methods of catheter ablation procedures studied in this report include radiofrequency, high intensity focused ultrasound (HIFU), cryoablation, microwave ablation and laser catheter ablation. Each of these segments and their sub-classification is analyzed on the basis of their market size and their forecast for the period 2011 to 2019, in terms of USD million. The compounded annual growth rate (CAGR) for all the above segments has been provided for the forecast period from 2013 o 2019, considering 2012 as the base year.

In terms of geography, the market for atrial fibrillation treatment has been categorized into four geographical markets namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for all the major segments, along with their growth rate, by regions has been provided in the report. The market overview section of the report includes the qualitative analysis of the atrial fibrillation treatment market in terms of environmental factors such as drivers, restraints and opportunities, market attractiveness analysis and Porter's five forces analysis.

The report is concluded with the competitive landscape section which comprises the strategic recommendations for the current and future market players and company profiles of the existing market players in terms of their market share (value %) for the year 2012. Some of the major market players profiled in the report include St. Jude Medical, Boehringer Ingelheim, Boston Scientific Corporation, AtriCure, Inc., Johnson & Johnson and Bayer (Xeralto), Sanofi, CardioFocus, Endoscopic Technologies, Bristol Myers-Pfizer, Biosense Wesbter and others.

The global atrial fibrillation market is categorized into the following segments:

Atrial Fibrillation Market, by Treatment Types

  • Pharmacological Treatment
    • Anti-Arrhythmic Drugs
    • Anti-Coagulant Drugs
  • Non-Pharmacological Treatment
    • Catheter Ablation
    • Radiofrequency Based
    • Cryoablation Based
    • HIFU (High Intensity Focused Ultrasound) Based
    • Microwave Based
    • Laser Based
    • Maze Surgery
    • Electric Cardioversion

Atrial Fibrillation Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Preface

  • 1.1. Report description
  • 1.2. Market segmentation
  • 1.3. Research methodology

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Rising global base of geriatric population
      • 3.2.1.2. Favorable results exhibited by clinical trials aimed at treating atrial fibrillation
      • 3.2.1.3. Rising prevalence of disorders such as hypertension and obesity accelerating the incidence rate of atrial fibrillation
    • 3.2.2. Restraints
      • 3.2.2.1. Stringent FDA, CE and European Medicines Agency product approval regulations
    • 3.2.3. Opportunities
      • 3.2.3.1. Introduction of innovative treatment procedures
      • 3.2.3.2. Rising prevalence of atrial fibrillation in emerging Asian economies
  • 3.3. Porter's Five Forces Analysis for the Global Atrial Fibrillation Market
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Bargaining Power of Buyers
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Threat of New Entrants
    • 3.3.5. Competitive Rivalry

Chapter 4 - Atrial Fibrillation Market, by Treatment Types

  • 4.1. Overview
    • 4.1.1. Global Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • 4.2. Global Pharmacological Treatments for Atrial Fibrillation Market
    • 4.2.1. Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
    • 4.2.2. Global Anti-Arrhythmic Drugs Market
      • 4.2.2.1. Global Anti-Arrhythmic Drugs Market, 2011 - 2019 (USD Million)
    • 4.2.3. Global Anti-Coagulants Market
      • 4.2.3.1. Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • 4.3. Non-Pharmacological Treatment for Atrial Fibrillation Market
    • 4.3.1. Overview: Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
    • 4.3.2. Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
    • 4.3.3. Global Catheter Ablation Treatment for Atrial Fibrillation Market
      • 4.3.3.1. Overview
      • 4.3.3.2. Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
      • 4.3.3.3. Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
      • 4.3.3.4. Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
      • 4.3.3.5. Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
      • 4.3.3.6. Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
      • 4.3.3.7. Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
    • 4.3.4. Global Maze Surgery for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
    • 4.3.5. Global Electric Cardioversion for Atrial Fibrillation Market, 2011 - 2019 (USD Million)

Chapter 5 - Atrial Fibrillation Market, by Geography

  • 5.1. Overview
  • 5.2. North America
    • 5.2.1. North America Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)
  • 5.4. Asia-Pacific
    • 5.4.1. Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)
  • 5.5. Rest of the World (RoW)
    • 5.5.1. RoW Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)

Chapter 6 - Competitive Landscape

Chapter 7 - Recommendations

  • 7.1 Investing in emerging markets, particularly China and Brazil
  • 7.2 Focus on emerging technologies such as mini-maze procedure and catheter ablation

Chapter 8 - Company Profiles

  • 8.1. AtriCure, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
  • 8.2. Biosense Webster, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Product Portfolio
    • 8.2.3. Business Strategies
  • 8.3. Boehringer Ingelheim GmbH
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. Boston Scientific Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
  • 8.5. Bristol-Myers Squibb Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
  • 8.6. CardioFocus, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Product Portfolio
  • 8.7. Endoscopic Technologies, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Product Portfolio
    • 8.7.3. Business Strategies
  • 8.8. Sanofi Aventis
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
  • 8.9. St. Jude Medical, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
  • 8.10. Johnson and Johnson Ltd
    • 8.10.1. Company Overview
    • 8.10.2. Financial Overview
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategies

List of Figures

  • FIG. 1: Market Segmentation: Global Atrial Fibrillation Market
  • FIG. 2: Global Atrial Fibrillation Market, by Treatment Types, 2012 (USD Million)
  • FIG. 3: Global Population, by Age-Group, 2000 & 2050 (%)
  • FIG. 4: Porter's Five Forces Analysis for the Global Atrial Fibrillation Market
  • FIG. 5: Comparative Analysis of the Global Atrial Fibrillation Market, by Treatment Types, 2012 & 2019 (%)
  • FIG. 6: Global Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 7: Global Pharmacological Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 8: Global Anti-Arrhythmic Drugs Market, 2011 - 2019 (USD Million)
  • FIG. 9: Global Anti-Coagulant Drugs for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 10: Comparative Analysis of the Non-Pharmacological Treatment for Atrial Fibrillation Market
  • FIG. 11: Global Non-Pharmacological Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 12: Comparative Analysis: Catheter Ablation Treatment Types for the Atrial Fibrillation Market
  • FIG. 13: Global Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 14: Global Radiofrequency Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 15: Global HIFU (High Intensity Focused Ultrasound) Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 16: Global Cryoablation Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 17: Global Microwave Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 18: Global Laser Based Catheter Ablation Treatment for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 19: Global Maze Surgery for Atrial Fibrillation Market, 2013 - 2019 (USD Million)
  • FIG. 20: Global Electric Cardioversion for Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 21: Comparative Analysis of the Global Atrial Fibrillation Market, by Geography, 2012 & 2019 (%)
  • FIG. 22: North America Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 23: Europe Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 24: Asia-Pacific Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 25: RoW Atrial Fibrillation Market, 2011 - 2019 (USD Million)
  • FIG. 26: AtriCure Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 27: Boehringer Ingelheim: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 28: Boston Scientific: Annual sales revenue, 2010 - 2012 (USD Million)
  • FIG. 29: Bristol-Myers Squibb: Annual sales revenue, 2010 - 2012 (USD Million)
  • FIG. 30: Sanofi: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 31: St. Jude Medical: Annual Sales Revenue, 2010 - 2012 (USD Million)
  • FIG. 32: Johnson and Johnson: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1: Market Snapshot: Global Atrial Fibrillation Market
  • TABLE 2: Impact analysis of the Market Drivers for the Global Atrial Fibrillation Market
  • TABLE 3: Impact analysis of the Market Restraints for the Global Atrial Fibrillation Market
  • TABLE 4: Anti-Arrhythmic Drug Types and Clinical Usage
  • TABLE 5: Anti-Arrhythmic Drugs: Classification and Clinical Usage
  • TABLE 6: North America Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)
  • TABLE 7: Europe Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)
  • TABLE 8: Asia-Pacific Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)
  • TABLE 9: RoW Atrial Fibrillation Market, by Treatment Types, 2011 - 2019 (USD Million)
Back to Top